TCG Crossover Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

TCG Crossover Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,750,387	Closed	-$61.2M	–	35
2024 Q1	$61.2M	Hold	1,750,387	–	–	4.84%	7
2023 Q4	$66.5M	Hold	1,750,387	–	–	7.38%	2
2023 Q3	$32.1M	Buy	+1,750,387	New	+$36.6M	4.73%	8

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

TCG Crossover Management's INBX Position: Q2 2024 in Review

TCG Crossover Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 1,750,387 shares — an estimated $61.2M sold.

TCG Crossover Management first reported a position in INBX in Q3 2023 and held it in 3 quarters. The position peaked at $66.5M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

TCG Crossover Management reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
TCG Crossover Management sold 1,750,387 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $61.2M.
TCG Crossover Management first reported a position in Inhibrx, Inc. Common Stock in Q3 2023 and held it in 3 quarters.
TCG Crossover Management's Inhibrx, Inc. Common Stock position peaked at $66.5M in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on TCG Crossover Management's 13F filing for Q2 2024, filed 14 Aug 2024.